Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

624 recalls, newest first

Class II · Moderate risk

Trelstar (triptorelin pamoate)

Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.

Terminated Labeling / mix-up Actavis Inc NDC 52544-154-02 D-1085-2014
Class II · Moderate risk

0.45% Sodium Chloride Injection USP

Labeling: Wrong Bar Code; Bar code scans as 0.15% Potassium Chloride in 0.9% Sodium Chloride (20 mEq K/liter).

Terminated Labeling / mix-up B. Braun Medical Inc NDC 0264-7802-00 D-407-2014
Class III · Low risk

Paclitaxel Injection

Labeling: Incorrect or Missing Package Insert- Missing text on the product insert in the "Clinical Studies" and "Specific Adverse Events" sections.

Terminated Labeling / mix-up Fresenius Kabi USA, LLC NDC 63323-763-50 D-016-2014
Class II · Moderate risk

Carbon Dioxide

Labeling: Not Elsewhere Classified; Due to an error in the manufacturing procedure, a cylinder in liquid withdrawal service was not marked Syphon Tube indicating liquid withdrawal and shipped as a gas withdrawal cylinder.

Terminated Labeling / mix-up Airgas Medical Services D-366-2014
Class II · Moderate risk

sertraline HCl tablets

Labeling: Incorrect or Missing Lot No. and/or Exp Date: Expiration date incorrectly reflects a 36 month shelf life, instead of the 24 month shelf life

Terminated Labeling / mix-up Greenstone LLC NDC 59762-4960-1 D-746-2014
Class II · Moderate risk

Nifedipine

Labeling: Incorrect or Missing Lot and/or Exp Date: Greenstone LLC is recalling Nifedipine Extended Release tablets (90mg). The expiration date on the package is 48 months instead of 36 months.

Terminated Labeling / mix-up Greenstone Llc NDC 59762-6692-8 D-737-2014
Class I · High risk

Human Chorionic Gonadotropin

Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.

Terminated Labeling / mix-up Medisca Inc. NDC 38779-2673-1 D-1263-2014
Class III · Low risk

Potassium Chloride

Labeling: Incorrect or Missing Package Insert: the package insert for the potassium chloride 8 mEq and 10 mEq strength instead of the potassium chloride 10 mEq and 20 mEq strength was packaged with the product.

Terminated Labeling / mix-up Cardinal Health D-0489-2015
Class III · Low risk

Acanya (Clindamycin Phosphate and Benzoyl Peroxide)

Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being carried out due to an incorrect expiration date assigned to a lot of physicians samples.

Terminated Labeling / mix-up Valeant Pharmaceuticals North Am NDC 13548-132-03 D-020-2014
Class II · Moderate risk

Ibu (NDC 55111-684-05)

Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.

Terminated Labeling / mix-up Dr. Reddy's Laboratories, Inc. NDC 55111-684-05 D-1042-2013
Class II · Moderate risk

K Effervescent Tablets

LABELING: Label Mix-up: 30 count Effervescent Potassium/Chloride Tablets, may be labeled as 30 count K Effervescent Tablets.

Terminated Labeling / mix-up Qualitest Pharmaceuticals D-1036-2013
Class III · Low risk

Introvale (levonorgestrel and ethinyl estradiol)

Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card

Terminated Labeling / mix-up Sandoz Incorporated NDC 0781-5584-36 D-854-2013
Class III · Low risk

Maalox

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-907-2013
Class III · Low risk

Maalox Extra Strength Antacid

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-906-2013
Class III · Low risk

Maalox Regular Strength Antacid

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-903-2013
Class III · Low risk

Clobetasol Propionate Cream

Labeling: Label Mix-up; some cartons labeled as Clobetasol Propionate Cream USP contain tubes labeled as Clobetasol Propionate Gel USP. The actual product in the tube is Clobetasol Propionate Cream USP

Terminated Labeling / mix-up Hi-Tech Pharmacal Co., Inc. NDC 50383-267-15 D-888-2013
Class II · Moderate risk

Terazosin Hydrochloride Capsules

Labeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg Capsules

Terminated Labeling / mix-up Teva Pharmaceuticals USA, Inc. NDC 0093-4339-01 D-842-2013

Recalls by year